29.9 C
Vientiane
Thursday, August 7, 2025
spot_img
Home Blog Page 120

Binance integrates Tokenized Real-World Assets USYC and cUSDO into Off-Exchange Settlement Solutions

Largest crypto exchange will waive banking triparty fee and absorb institutional custody partner Ceffu’s MirrorX and MirrorRSV service fees until 2026 

DUBAI, UAE, July 24, 2025 /PRNewswire/ — Binance, the world’s leading blockchain ecosystem behind the largest cryptocurrency exchange by trading volume and user base, is pleased to announce it will support tokenized yield-bearing assets USYC and cUSDO through Binance Banking Triparty as well as through its institutional custody partner Ceffu, giving institutional users the additional choice of holding USYC and cUSDO off-exchange while simultaneously enjoying seamless access to the Binance platform and receiving yield on their pledged collateral.

This integration expands the range of supported collateral for institutional users beyond traditional assets such as fiat currencies and Treasury bills on Binance Banking Triparty, and beyond native crypto assets such as bitcoin on Ceffu.

Tokenization of real-world assets excluding stablecoins has increased to $24 billion in June 2025 from $15.2 billion in December 2024, and is projected to reach up to 30% of traditional finance assets worth over $400 trillion by 2034, indicating a potential exponential growth of over 100x for crypto which currently has a market cap of $3 trillion.

“Our integration of tokenized real-world assets demonstrates our continued focus to enhance user experience on Binance. By supporting USYC and cUSDO on Binance Banking Triparty as well as through our custody partner Ceffu, we are offering our institutional clients more choices to optimize their capital efficiency while balancing risk control requirements,” said Catherine Chen, Head of Binance VIP & Institutional. “Tokenization of real-world assets enables users to benefit from the inherent properties of digital assets, such as faster and cheaper settlement, 24/7 availability, and on-chain transparency, and will unlock further crypto adoption.”

“This collaboration with Binance marks a meaningful advancement in how institutions can engage with tokenized real-world assets,” said Kash Razzaghi, Chief Business Officer at Circle. “By making USYC available as off-exchange collateral with yield potential, we’re bringing capital efficiency and risk-managed optionality to institutional investors—bridging traditional finance and blockchain-powered markets.”

“We’re entering a new phase of institutional crypto adoption, where compliance focused, yield-bearing assets like cUSDO are becoming central to how capital is deployed on-chain,” said Jeremy Ng, Founder and CEO of OpenEden. “cUSDO’s integration into Binance Banking Triparty and their custody partner Ceffu showcases how institutional-grade RWAs can deliver the capital efficiency and security needed to drive meaningful participation from institutions.”

USYC is the digital representation of interests in Hashnote International Short Duration Yield Fund Ltd, a tokenized money market fund (TMMF) registered in the Cayman Islands (the “Fund”). The Fund invests primarily in reverse repurchase agreements backed by U.S. government securities. The Fund offers near-instant redemption into USDC. USYC will also be natively issued on BNB Chain, increasing its on-chain accessibility to more users.

cUSDO is a wrapped version of OpenEden OpenDollar (“USDO”), a rebasing yield-bearing stablecoin issued by OpenEden Digital, a Bermuda-licensed and regulated entity. cUSDO and USDO let holders earn yield generated from reserves backed by U.S. Treasury bills and reverse repurchase agreements.

Binance’s Global and Growing Banking Triparty Coverage

Binance was the first crypto exchange to introduce a triparty banking solution modeled after traditional finance in 2023, enabling institutional clients to custody their trading collateral under their own corporate account with a network of regulated banking partners, while enjoying seamless access to Binance’s full suite of institutional solutions and unparalleled deep liquidity.

To meet demand, Binance has expanded its network of triparty bank partners to enable institutional clients worldwide to meet their risk controls and confidently enter crypto while scaling for growth. With Binance Banking Triparty, clients can scale their trading activity on Binance in line with their capital, directly enhancing liquidity on the exchange to benefit all users.

From now until 2026, Binance is waiving banking triparty fees and will also absorb Ceffu’s MirrorX and MirrorRSV service fees to help more institutions accelerate their adoption. Users interested in Binance’s off-exchange solutions can visit Binance Banking Triparty and Ceffu, or contact their Binance VIP & Institutional representative.

Disclaimer

USYC is a digital asset token. Each USYC token serves as a digital representation of a share of the Hashnote International Short Duration Fund Ltd. (the “Fund”), a Cayman Islands registered mutual fund. The Fund has appointed Circle International Bermuda Limited (“CIBL”), a Bermuda Monetary Authority licensed digital asset business, as its token administrator, responsible for the management of USYC on behalf of the Fund.
Shares of the Fund and USYC are only available to non-U.S. Persons, as defined under the Securities Act of 1933, as amended. Additional eligibility restrictions may apply. For additional details or to request Fund documentation, please contact customer-support@circle.com.

References to the digital assets (USDO and its wrapped version cUSDO) in this communication herein are for information purposes only and are not intended to and do not constitute an offer to sell or the solicitation of an offer to buy, or an invitation to purchase, exchange or subscribe for USDO or cUSDO. USDO and cUSDO are digital assets issued by OpenEden Digital, a digital asset issuer licensed by the Bermuda Monetary Authority and have not been and will not be registered with any regulatory authority or framework, including under the US Securities Act of 1933, as amended, and may not be offered or sold in the US or such other restricted jurisdictions, including jurisdictions where such offer or sale is in contravention of applicable law, except pursuant to an applicable exemption from registration. No public offering of USDO and cUSDO is being made in the US or restricted jurisdictions. To learn more, please visit https://openeden.com/ 

Digital asset prices are subject to high market risk and price volatility. The value of your investment may go down or up, and you may not get back the amount invested. Past performance is not a reliable indicator of future performance. You are solely responsible for your investment decisions and Binance is not liable for any losses you may incur. You should only invest in products you are familiar with and where you understand the risks. You should carefully consider your investment experience, financial situation, investment objectives and risk tolerance and consult an independent financial adviser prior to making any investment. This material should not be construed as financial advice. For more information, see our Terms of Use and Risk Warning.

About Binance

Binance is a leading global blockchain ecosystem behind the world’s largest cryptocurrency exchange by trading volume and registered users. Binance is trusted by more than 280 million people in 100+ countries for its industry-leading security, transparency, trading engine speed, protections for investors, and unmatched portfolio of digital asset products and offerings from trading and finance to education, research, social good, payments, institutional services, and Web3 features. Binance is devoted to building an inclusive crypto ecosystem to increase the freedom of money and financial access for people around the world with crypto as the fundamental means.

For more information, visit: https://www.binance.com 

Binance integrates Tokenized Real-World Assets USYC and cUSDO into Off-Exchange Settlement Solutions

Largest crypto exchange will waive banking triparty fee and absorb institutional custody partner Ceffu’s MirrorX and MirrorRSV service fees until 2026 

DUBAI, UAE, July 24, 2025 /PRNewswire/ — Binance, the world’s leading blockchain ecosystem behind the largest cryptocurrency exchange by trading volume and user base, is pleased to announce it will support tokenized yield-bearing assets USYC and cUSDO through Binance Banking Triparty as well as through its institutional custody partner Ceffu, giving institutional users the additional choice of holding USYC and cUSDO off-exchange while simultaneously enjoying seamless access to the Binance platform and receiving yield on their pledged collateral.

This integration expands the range of supported collateral for institutional users beyond traditional assets such as fiat currencies and Treasury bills on Binance Banking Triparty, and beyond native crypto assets such as bitcoin on Ceffu.

Tokenization of real-world assets excluding stablecoins has increased to $24 billion in June 2025 from $15.2 billion in December 2024, and is projected to reach up to 30% of traditional finance assets worth over $400 trillion by 2034, indicating a potential exponential growth of over 100x for crypto which currently has a market cap of $3 trillion.

“Our integration of tokenized real-world assets demonstrates our continued focus to enhance user experience on Binance. By supporting USYC and cUSDO on Binance Banking Triparty as well as through our custody partner Ceffu, we are offering our institutional clients more choices to optimize their capital efficiency while balancing risk control requirements,” said Catherine Chen, Head of Binance VIP & Institutional. “Tokenization of real-world assets enables users to benefit from the inherent properties of digital assets, such as faster and cheaper settlement, 24/7 availability, and on-chain transparency, and will unlock further crypto adoption.”

“This collaboration with Binance marks a meaningful advancement in how institutions can engage with tokenized real-world assets,” said Kash Razzaghi, Chief Business Officer at Circle. “By making USYC available as off-exchange collateral with yield potential, we’re bringing capital efficiency and risk-managed optionality to institutional investors—bridging traditional finance and blockchain-powered markets.”

“We’re entering a new phase of institutional crypto adoption, where compliance focused, yield-bearing assets like cUSDO are becoming central to how capital is deployed on-chain,” said Jeremy Ng, Founder and CEO of OpenEden. “cUSDO’s integration into Binance Banking Triparty and their custody partner Ceffu showcases how institutional-grade RWAs can deliver the capital efficiency and security needed to drive meaningful participation from institutions.”

USYC is the digital representation of interests in Hashnote International Short Duration Yield Fund Ltd, a tokenized money market fund (TMMF) registered in the Cayman Islands (the “Fund”). The Fund invests primarily in reverse repurchase agreements backed by U.S. government securities. The Fund offers near-instant redemption into USDC. USYC will also be natively issued on BNB Chain, increasing its on-chain accessibility to more users.

cUSDO is a wrapped version of OpenEden OpenDollar (“USDO”), a rebasing yield-bearing stablecoin issued by OpenEden Digital, a Bermuda-licensed and regulated entity. cUSDO and USDO let holders earn yield generated from reserves backed by U.S. Treasury bills and reverse repurchase agreements.

Binance’s Global and Growing Banking Triparty Coverage

Binance was the first crypto exchange to introduce a triparty banking solution modeled after traditional finance in 2023, enabling institutional clients to custody their trading collateral under their own corporate account with a network of regulated banking partners, while enjoying seamless access to Binance’s full suite of institutional solutions and unparalleled deep liquidity.

To meet demand, Binance has expanded its network of triparty bank partners to enable institutional clients worldwide to meet their risk controls and confidently enter crypto while scaling for growth. With Binance Banking Triparty, clients can scale their trading activity on Binance in line with their capital, directly enhancing liquidity on the exchange to benefit all users.

From now until 2026, Binance is waiving banking triparty fees and will also absorb Ceffu’s MirrorX and MirrorRSV service fees to help more institutions accelerate their adoption. Users interested in Binance’s off-exchange solutions can visit Binance Banking Triparty and Ceffu, or contact their Binance VIP & Institutional representative.

Disclaimer

USYC is a digital asset token. Each USYC token serves as a digital representation of a share of the Hashnote International Short Duration Fund Ltd. (the “Fund”), a Cayman Islands registered mutual fund. The Fund has appointed Circle International Bermuda Limited (“CIBL”), a Bermuda Monetary Authority licensed digital asset business, as its token administrator, responsible for the management of USYC on behalf of the Fund.
Shares of the Fund and USYC are only available to non-U.S. Persons, as defined under the Securities Act of 1933, as amended. Additional eligibility restrictions may apply. For additional details or to request Fund documentation, please contact customer-support@circle.com.

References to the digital assets (USDO and its wrapped version cUSDO) in this communication herein are for information purposes only and are not intended to and do not constitute an offer to sell or the solicitation of an offer to buy, or an invitation to purchase, exchange or subscribe for USDO or cUSDO. USDO and cUSDO are digital assets issued by OpenEden Digital, a digital asset issuer licensed by the Bermuda Monetary Authority and have not been and will not be registered with any regulatory authority or framework, including under the US Securities Act of 1933, as amended, and may not be offered or sold in the US or such other restricted jurisdictions, including jurisdictions where such offer or sale is in contravention of applicable law, except pursuant to an applicable exemption from registration. No public offering of USDO and cUSDO is being made in the US or restricted jurisdictions. To learn more, please visit https://openeden.com/ 

Digital asset prices are subject to high market risk and price volatility. The value of your investment may go down or up, and you may not get back the amount invested. Past performance is not a reliable indicator of future performance. You are solely responsible for your investment decisions and Binance is not liable for any losses you may incur. You should only invest in products you are familiar with and where you understand the risks. You should carefully consider your investment experience, financial situation, investment objectives and risk tolerance and consult an independent financial adviser prior to making any investment. This material should not be construed as financial advice. For more information, see our Terms of Use and Risk Warning.

About Binance

Binance is a leading global blockchain ecosystem behind the world’s largest cryptocurrency exchange by trading volume and registered users. Binance is trusted by more than 280 million people in 100+ countries for its industry-leading security, transparency, trading engine speed, protections for investors, and unmatched portfolio of digital asset products and offerings from trading and finance to education, research, social good, payments, institutional services, and Web3 features. Binance is devoted to building an inclusive crypto ecosystem to increase the freedom of money and financial access for people around the world with crypto as the fundamental means.

For more information, visit: https://www.binance.com 

AMSC Malaysia 2025 Set to Spotlight World-Class Expertise and Innovation in Aesthetic Medicine and Surgery

KUALA LUMPUR, Malaysia, July 24, 2025 /PRNewswire/ — The Aesthetic Medicine & Surgery Conference & Exhibition (AMSC) returns for its fourth edition from August 6-7, 2025, with an expanded focus on global participation and advanced education. Held at the Kuala Lumpur Convention Centre (KLCC), AMSC 2025 will feature over 160 world-class speakers, 200 international brands, and 20 supporting partners, including 13 medical societies and 7 industry collaborators. More than 1,600 delegates from around the world are expected, with highlights including clinical innovation updates, live demonstrations, and expert insights from speakers representing over 30 countries.

AMSC Malaysia 2025 is expected to attract over 1,600 delegates from across the world.
AMSC Malaysia 2025 is expected to attract over 1,600 delegates from across the world.

“AMSC Malaysia 2025 represents a global crossroads for aesthetic medicine, where regional insights meet international expertise. This year, we are not just sharing techniques, we are also building a collaborative future for the field by fostering dialogue, discovery, and innovation across borders,” said Dr Tingsong Lim, President of the Malaysian Society of Aesthetic Medicine (MSAM) and Scientific Director of AMSC.

Elevating Aesthetic and Regenerative Care for Diverse Needs

AMSC Malaysia 2025 will explore a wide range of cutting-edge topics in aesthetic and regenerative medicine. These include Periorbital Rejuvenation, focusing on advanced techniques using fillers, threads, and devices to treat tear troughs and under-eye ageing; Melasma Management, with evidence-based protocols combining lasers, topicals, and regenerative treatments tailored for Asian skin; Facelift Techniques, covering both surgical and non-invasive approaches such as thread lifts, energy-based tightening, and facial sculpting; Longevity Medicine, exploring anti-ageing strategies that utilise semaglutide, hormones, peptides, and polydeoxyribonucleotides (PDRN); Regenerative Aesthetics, highlighting the use of exosomes, stem cells, and PRP to restore skin quality and stimulate collagen; Scar Treatment, featuring multi-modal solutions using lasers, injectables, and biostimulators for acne scars and post-surgical healing; and more.

Through these sessions, delegates will gain in-depth knowledge of current clinical trends, master advanced injection and device-based techniques, and learn how to apply combination approaches for improved patient outcomes. The conference provides ample opportunities for attendees to explore innovations in regenerative medicine, deepen their understanding of tailored treatments for diverse skin types and enhance their ability to meet the growing demands of specialised patient segments, including male aesthetics and ageing populations.

This year’s AMSC welcomes a distinguished line-up of global experts who are redefining the standards of aesthetic and regenerative medicine:

  • DrTingsong Lim (Malaysia) is an aesthetic doctor who has been involved in academic research and training on Asian facial and body aesthetics, clinical application of filler rheology, Facial Overfilled Syndrome, pigmentary disorders, energy-based medicine, and regenerative medicine. He is the President of the Malaysian Society of Aesthetic Medicine and a frequent speaker at top regional and international conferences.
  • DrGiovanni Salti (Italy) is a renowned plastic surgeon who specialises in fat surgery and regenerative fat therapy and has extensive global experience in nonsurgical cosmetic procedures. Over the last 20 years, he has been invited to numerous international scientific congresses and meetings on soft tissue fillers, botulinum toxin, cellulite, lasers, and minimally invasive aesthetics.
  • Dr Nino Reisener (Germany) is an aesthetic doctor with global clinical exposure who has performed over 25,000 injections. He brings deep industry knowledge from over eight years of experience with one of the largest companies in the injectable industry, as well as more than 300 hours of clinical mentorship.
  • DrMonika Kavkova (Czech Republic) is an internationally certified expert in aesthetic, anti-ageing, and regenerative medicine, as well as dermatologic surgery. She is the owner and leading doctor at BE ELITE CLINIC in Prague and the scientific board director of Prague LAB (Aesthetic Dialogue international symposium).
  • DrKyu-Ho Yi (South Korea) is an anatomist and adjunct professor at Yonsei University, with over 40 published papers. He is the Director of Maylin Clinic and Academic Director of the Korean Association of Laser, Dermatology, and Trichology.
  • DrDo Young Rhee (South Korea) is the Director of Heal House Dermatology and the Academic Director of KOREADERMA. A pioneer in combination therapies for Asian skin, he regularly speaks at the Aesthetic and Anti-Aging Medicine World Congress (AMWC), International Master Course on Aging Science (IMCAS), and KOREADERMA.
  • DrSusan Cheong (Macau SAR) is a plastic surgeon and PhD candidate at Southern Medical University, serving as International Liaison of the Chinese Association of Plastics and Aesthetics (CAPA). She bridges clinical aesthetics and scientific innovation, focusing on ECM-based regenerative strategies and anti-ageing innovations.

The PINOKIO Surgical Zone Returns with Expanded Hands-On Training

Returning for its eighth edition in Malaysia, the PINOKIO Surgical Zone at AMSC 2025 brings back Korea’s leading surgical organisation for an expanded three-day programme from 6 to 8 August 2025. In a groundbreaking collaboration, AMSC partners with the Plastic Innovative Nasal Ormaxillofacial Korean International Organisation (PINOKIO) to deliver an immersive and focused surgical education experience tailored for professionals seeking to refine their techniques and deepen their anatomical understanding.

The agenda includes Day 1: Nose Surgery Focus, Day 2: Face and Chest Lift Techniques, and Day 3: Hands-on Cadaver Masterclass on Rhinoplasty and Surgical Facelift. Delegates will benefit from expert-led lectures, live cadaver dissections, and practical demonstrations guided by some of Asia’s most respected surgeons. Additionally, the zone features a curated exhibition showcasing the latest tools and innovations in facial, nasal, and chest aesthetic surgery.

Additionally, the exhibition hall will feature leading global brands such as Merz Aesthetics, Juvederm, Skinvive, Neauvia, Oligio, Gouri, Karisma, Multifrax, Sinclair, and Plinest, offering delegates hands-on access to the latest innovations in injectables, energy-based devices, and regenerative solutions.

For more information about the event and to register, visit www.amsc.com.my.

AMSC Malaysia 2025 Set to Spotlight World-Class Expertise and Innovation in Aesthetic Medicine and Surgery

KUALA LUMPUR, Malaysia, July 24, 2025 /PRNewswire/ — The Aesthetic Medicine & Surgery Conference & Exhibition (AMSC) returns for its fourth edition from August 6-7, 2025, with an expanded focus on global participation and advanced education. Held at the Kuala Lumpur Convention Centre (KLCC), AMSC 2025 will feature over 160 world-class speakers, 200 international brands, and 20 supporting partners, including 13 medical societies and 7 industry collaborators. More than 1,600 delegates from around the world are expected, with highlights including clinical innovation updates, live demonstrations, and expert insights from speakers representing over 30 countries.

AMSC Malaysia 2025 is expected to attract over 1,600 delegates from across the world.
AMSC Malaysia 2025 is expected to attract over 1,600 delegates from across the world.

“AMSC Malaysia 2025 represents a global crossroads for aesthetic medicine, where regional insights meet international expertise. This year, we are not just sharing techniques, we are also building a collaborative future for the field by fostering dialogue, discovery, and innovation across borders,” said Dr Tingsong Lim, President of the Malaysian Society of Aesthetic Medicine (MSAM) and Scientific Director of AMSC.

Elevating Aesthetic and Regenerative Care for Diverse Needs

AMSC Malaysia 2025 will explore a wide range of cutting-edge topics in aesthetic and regenerative medicine. These include Periorbital Rejuvenation, focusing on advanced techniques using fillers, threads, and devices to treat tear troughs and under-eye ageing; Melasma Management, with evidence-based protocols combining lasers, topicals, and regenerative treatments tailored for Asian skin; Facelift Techniques, covering both surgical and non-invasive approaches such as thread lifts, energy-based tightening, and facial sculpting; Longevity Medicine, exploring anti-ageing strategies that utilise semaglutide, hormones, peptides, and polydeoxyribonucleotides (PDRN); Regenerative Aesthetics, highlighting the use of exosomes, stem cells, and PRP to restore skin quality and stimulate collagen; Scar Treatment, featuring multi-modal solutions using lasers, injectables, and biostimulators for acne scars and post-surgical healing; and more.

Through these sessions, delegates will gain in-depth knowledge of current clinical trends, master advanced injection and device-based techniques, and learn how to apply combination approaches for improved patient outcomes. The conference provides ample opportunities for attendees to explore innovations in regenerative medicine, deepen their understanding of tailored treatments for diverse skin types and enhance their ability to meet the growing demands of specialised patient segments, including male aesthetics and ageing populations.

This year’s AMSC welcomes a distinguished line-up of global experts who are redefining the standards of aesthetic and regenerative medicine:

  • DrTingsong Lim (Malaysia) is an aesthetic doctor who has been involved in academic research and training on Asian facial and body aesthetics, clinical application of filler rheology, Facial Overfilled Syndrome, pigmentary disorders, energy-based medicine, and regenerative medicine. He is the President of the Malaysian Society of Aesthetic Medicine and a frequent speaker at top regional and international conferences.
  • DrGiovanni Salti (Italy) is a renowned plastic surgeon who specialises in fat surgery and regenerative fat therapy and has extensive global experience in nonsurgical cosmetic procedures. Over the last 20 years, he has been invited to numerous international scientific congresses and meetings on soft tissue fillers, botulinum toxin, cellulite, lasers, and minimally invasive aesthetics.
  • Dr Nino Reisener (Germany) is an aesthetic doctor with global clinical exposure who has performed over 25,000 injections. He brings deep industry knowledge from over eight years of experience with one of the largest companies in the injectable industry, as well as more than 300 hours of clinical mentorship.
  • DrMonika Kavkova (Czech Republic) is an internationally certified expert in aesthetic, anti-ageing, and regenerative medicine, as well as dermatologic surgery. She is the owner and leading doctor at BE ELITE CLINIC in Prague and the scientific board director of Prague LAB (Aesthetic Dialogue international symposium).
  • DrKyu-Ho Yi (South Korea) is an anatomist and adjunct professor at Yonsei University, with over 40 published papers. He is the Director of Maylin Clinic and Academic Director of the Korean Association of Laser, Dermatology, and Trichology.
  • DrDo Young Rhee (South Korea) is the Director of Heal House Dermatology and the Academic Director of KOREADERMA. A pioneer in combination therapies for Asian skin, he regularly speaks at the Aesthetic and Anti-Aging Medicine World Congress (AMWC), International Master Course on Aging Science (IMCAS), and KOREADERMA.
  • DrSusan Cheong (Macau SAR) is a plastic surgeon and PhD candidate at Southern Medical University, serving as International Liaison of the Chinese Association of Plastics and Aesthetics (CAPA). She bridges clinical aesthetics and scientific innovation, focusing on ECM-based regenerative strategies and anti-ageing innovations.

The PINOKIO Surgical Zone Returns with Expanded Hands-On Training

Returning for its eighth edition in Malaysia, the PINOKIO Surgical Zone at AMSC 2025 brings back Korea’s leading surgical organisation for an expanded three-day programme from 6 to 8 August 2025. In a groundbreaking collaboration, AMSC partners with the Plastic Innovative Nasal Ormaxillofacial Korean International Organisation (PINOKIO) to deliver an immersive and focused surgical education experience tailored for professionals seeking to refine their techniques and deepen their anatomical understanding.

The agenda includes Day 1: Nose Surgery Focus, Day 2: Face and Chest Lift Techniques, and Day 3: Hands-on Cadaver Masterclass on Rhinoplasty and Surgical Facelift. Delegates will benefit from expert-led lectures, live cadaver dissections, and practical demonstrations guided by some of Asia’s most respected surgeons. Additionally, the zone features a curated exhibition showcasing the latest tools and innovations in facial, nasal, and chest aesthetic surgery.

Additionally, the exhibition hall will feature leading global brands such as Merz Aesthetics, Juvederm, Skinvive, Neauvia, Oligio, Gouri, Karisma, Multifrax, Sinclair, and Plinest, offering delegates hands-on access to the latest innovations in injectables, energy-based devices, and regenerative solutions.

For more information about the event and to register, visit www.amsc.com.my.

Intelligent Living Application Group Inc. Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

HONG KONG, July 24, 2025 /PRNewswire/ — Intelligent Living Application Group Inc. (NASDAQ: ILAG) (“Intelligent Living” or the “Company”), a premium lockset manufacturer in Hong Kong, announced today that, on July 23, 2025, the Company received a written notification from the NASDAQ Stock Market Listing Qualifications Staff (the “Staff”) indicating that the Company has been granted an additional 180 calendar day period or until January 19, 2026, to regain compliance with the $1.00 minimum closing bid price requirement for continued listing on the NASDAQ Capital Market pursuant to NASDAQ Listing Rule (the “Minimum Bid Price Requirement”).

NASDAQ’s determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the NASDAQ Capital Market, with the exception of the bid price requirement, and the Company’s written notice to NASDAQ of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If at any time during this additional time period the closing bid price of the Company’s security is at least $1.00 per share for a minimum of 10 consecutive business days, NASDAQ will provide written confirmation of compliance and this matter will be closed. If compliance cannot be demonstrated by January 19, 2026, Staff will provide written notification that the Company’s securities will be delisted. At that time, the Company may appeal the Staff’s determination to a Hearings Panel (the “Panel”) of NASDAQ.

This notification from Nasdaq has no immediate effect on the listing or trading of the Company’s ordinary shares, which will continue to trade on the Nasdaq Capital Market under the symbol “ILAG”. The Company will monitor the closing bid price of its ordinary shares and will consider various options to regain compliance before January 19, 2026.

About Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc. is a premium lockset manufacturer and distributor headquartered in Hong Kong. Intelligent Living manufactures and sells high quality mechanical locksets to customers mainly in the United States and Canada and has continued to diversify and refine its product offerings in the past 40 years to meet its customers’ needs. Intelligent Living obtained the ISO9001 quality assurance certificate and various accredited quality and safety certificates including American National Standards Institute (ANSI) Grade 2 and Grade 3 standards that are developed by the Builders Hardware Manufacturing Association (BHMA) for ANSI. Intelligent Living keeps investing in self-designed automated product lines, new craftsmanship, and developing new products, including smart locks. For more information, visit the Company’s website at http://www.i-l-a-g.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC, which are available for review at www.sec.gov.

For more information, please contact:

Intelligent Living Application Group, Inc.
Phone: +852 2481 7938
Email info@i-l-a-g.com

Cognizant’s AI Lab Records 59th U.S. Patent, Continuing to Generate AI Breakthroughs

In 2025, the Lab has yielded two new U.S. Granted Patents, open-sourced a key AI development platform, and earned a Gold Award from GECCO

TEANECK, N.J., July 24, 2025 /PRNewswire/ — Cognizant (Nasdaq: CTSH) today announced that its AI Lab has been granted two new U.S. patents and a gold award for a research paper on “Realizing Human Expertise through AI” presented this month at GECCO (Genetic and Evolutionary Computation Conference) in Malaga, Spain.

Cognizant’s AI Lab displays 59 patents, with space for the 23 pending patents. The Lab celebrates each inventor with a U.S. Patent plaque and a FunkoPop figurine of their choice.
Cognizant’s AI Lab displays 59 patents, with space for the 23 pending patents. The Lab celebrates each inventor with a U.S. Patent plaque and a FunkoPop figurine of their choice.

“Being granted two new U.S. patents in the first half of 2025—bringing our AI Lab’s U.S. total to 59 with 23 more patents pending—underscores our relentless pace of innovation,” said Babak Hodjat, CTO of AI at Cognizant. “Couple this with a Gold Award at GECCO and these milestones reflect our deep commitment to pioneering transformative AI technologies and turning cutting-edge ideas into real-world impact.”

The two latest patents highlight key innovations from Cognizant’s AI research:

  • U.S. Patent No. 12,282,845 (issued on April 22, 2025) covers a method for Multi-objective Coevolution of Deep Neural Network Architectures, aimed at improving model performance and resource efficiency. The method’s application ranges from medical image classification to natural language processing.
  • U.S. Patent No. 12,292,944 (issued on May 6, 2025) outlines a method for optimizing loss functions through Taylor Series Expansion, aiming to improve training efficiency and enhance model robustness, especially is data-limited scenarios.1

These innovations, developed by Cognizant’s researchers including Dr. Jason Liang, Dr. Elliot Meyerson and Professor Risto Miikkulainen, reinforce Cognizant’s leadership in pushing the boundaries of AI and machine learning.

To make the promise of artificial intelligence both more practical and broadly accessible, earlier this year, Cognizant’s AI Lab open sourced its Neuro AI Multi-Agent Accelerator. Neuro AI helps businesses accelerate their development and adoption of AI agents, transforming their business processes for adaptive operations, real-time decision-making, and personalized customer experiences tailored to client-defined objectives and oversight.

The Cognizant AI Lab, which opened its San Francisco-based flagship AI research facility in March 2024, has also been honored with the Gold Award for Human-Competitive Results at GECCO 2025 for its groundbreaking work on RHEA (Realizing Human Expertise through AI). Developed by Dr. Elliott Meyerson and Professor Risto Miikkulainen RHEA employs evolutionary AI to distill and recombine hundreds of models generated by human expert teams—most notably those submitted to the XPRIZE Pandemic Response Challenge—into refined decision strategies. In a rigorous evaluation, RHEA surpassed the performance of individual human submissions, realizing the latent potential even in incompletely developed human ideas, resulting in innovative pandemic policy recommendations. This milestone underlines Cognizant’s leadership in harnessing global human expertise to drive next‑generation AI solutions.

Risto Miikkulainen, VP of Research and Professor of Computer Science at UT Austin, said, “RHEA is a powerful example of how evolutionary AI can amplify global human intelligence—not just by matching expert solutions, but by going beyond them to discover novel, high-impact strategies. This recognition by the Humies Award committee reinforces the promise of population-based AI as a foundation for solving the world’s most complex challenges.”

About Cognizant 
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we’re improving everyday life. See how at www.cognizant.com or @cognizant.

About the Cognizant AI Lab
The mission of the Cognizant AI Lab is to maximize human potential with Decision AI, a form of AI that combines generative AI, multi-agent architecture, deep learning, and evolutionary AI to create sophisticated decision-making systems. Decision AI powers Cognizant’s Neuro® AI platform, which is utilized by Fortune 500 companies and non-profits to discover new ways to exceed their goals. The platform enables organizations to rapidly build AI that optimizes decision-making, leading to revenue growth and societal progress. 

Led by AI pioneers Babak Hodjat and Risto Miikkulainen, the lab collaborates with institutions, academia, and technology partners to develop groundbreaking AI solutions responsibly. With over 120 patents (issued or pending) globally, the lab excels at combining scientific innovation with commercial application. It supports Cognizant’s goal of improving everyday life, focusing on business and AI-for-good applications.

For more information, contact:

Jeff DeMarrais:
Jeff.demarrais@cognizant.com

 

Paul Jarratt:
Paul.Jarratt@Cognizant.com

 

Gabrielle Gugliocciello:
gabrielle.gugliocciello@cognizant.com

_____________________________

1

Descriptions of patented technologies are simplified for general understanding. For full legal scope, please
refer to the issued patents linked above

 

 

Cognizant’s AI Lab Records 59th U.S. Patent, Continuing to Generate AI Breakthroughs

In 2025, the Lab has yielded two new U.S. Granted Patents, open-sourced a key AI development platform, and earned a Gold Award from GECCO

TEANECK, N.J., July 24, 2025 /PRNewswire/ — Cognizant (Nasdaq: CTSH) today announced that its AI Lab has been granted two new U.S. patents and a gold award for a research paper on “Realizing Human Expertise through AI” presented this month at GECCO (Genetic and Evolutionary Computation Conference) in Malaga, Spain.

Cognizant’s AI Lab displays 59 patents, with space for the 23 pending patents. The Lab celebrates each inventor with a U.S. Patent plaque and a FunkoPop figurine of their choice.
Cognizant’s AI Lab displays 59 patents, with space for the 23 pending patents. The Lab celebrates each inventor with a U.S. Patent plaque and a FunkoPop figurine of their choice.

“Being granted two new U.S. patents in the first half of 2025—bringing our AI Lab’s U.S. total to 59 with 23 more patents pending—underscores our relentless pace of innovation,” said Babak Hodjat, CTO of AI at Cognizant. “Couple this with a Gold Award at GECCO and these milestones reflect our deep commitment to pioneering transformative AI technologies and turning cutting-edge ideas into real-world impact.”

The two latest patents highlight key innovations from Cognizant’s AI research:

  • U.S. Patent No. 12,282,845 (issued on April 22, 2025) covers a method for Multi-objective Coevolution of Deep Neural Network Architectures, aimed at improving model performance and resource efficiency. The method’s application ranges from medical image classification to natural language processing.
  • U.S. Patent No. 12,292,944 (issued on May 6, 2025) outlines a method for optimizing loss functions through Taylor Series Expansion, aiming to improve training efficiency and enhance model robustness, especially is data-limited scenarios.1

These innovations, developed by Cognizant’s researchers including Dr. Jason Liang, Dr. Elliot Meyerson and Professor Risto Miikkulainen, reinforce Cognizant’s leadership in pushing the boundaries of AI and machine learning.

To make the promise of artificial intelligence both more practical and broadly accessible, earlier this year, Cognizant’s AI Lab open sourced its Neuro AI Multi-Agent Accelerator. Neuro AI helps businesses accelerate their development and adoption of AI agents, transforming their business processes for adaptive operations, real-time decision-making, and personalized customer experiences tailored to client-defined objectives and oversight.

The Cognizant AI Lab, which opened its San Francisco-based flagship AI research facility in March 2024, has also been honored with the Gold Award for Human-Competitive Results at GECCO 2025 for its groundbreaking work on RHEA (Realizing Human Expertise through AI). Developed by Dr. Elliott Meyerson and Professor Risto Miikkulainen RHEA employs evolutionary AI to distill and recombine hundreds of models generated by human expert teams—most notably those submitted to the XPRIZE Pandemic Response Challenge—into refined decision strategies. In a rigorous evaluation, RHEA surpassed the performance of individual human submissions, realizing the latent potential even in incompletely developed human ideas, resulting in innovative pandemic policy recommendations. This milestone underlines Cognizant’s leadership in harnessing global human expertise to drive next‑generation AI solutions.

Risto Miikkulainen, VP of Research and Professor of Computer Science at UT Austin, said, “RHEA is a powerful example of how evolutionary AI can amplify global human intelligence—not just by matching expert solutions, but by going beyond them to discover novel, high-impact strategies. This recognition by the Humies Award committee reinforces the promise of population-based AI as a foundation for solving the world’s most complex challenges.”

About Cognizant 
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we’re improving everyday life. See how at www.cognizant.com or @cognizant.

About the Cognizant AI Lab
The mission of the Cognizant AI Lab is to maximize human potential with Decision AI, a form of AI that combines generative AI, multi-agent architecture, deep learning, and evolutionary AI to create sophisticated decision-making systems. Decision AI powers Cognizant’s Neuro® AI platform, which is utilized by Fortune 500 companies and non-profits to discover new ways to exceed their goals. The platform enables organizations to rapidly build AI that optimizes decision-making, leading to revenue growth and societal progress. 

Led by AI pioneers Babak Hodjat and Risto Miikkulainen, the lab collaborates with institutions, academia, and technology partners to develop groundbreaking AI solutions responsibly. With over 120 patents (issued or pending) globally, the lab excels at combining scientific innovation with commercial application. It supports Cognizant’s goal of improving everyday life, focusing on business and AI-for-good applications.

For more information, contact:

Jeff DeMarrais:
Jeff.demarrais@cognizant.com

 

Paul Jarratt:
Paul.Jarratt@Cognizant.com

 

Gabrielle Gugliocciello:
gabrielle.gugliocciello@cognizant.com

_____________________________

1

Descriptions of patented technologies are simplified for general understanding. For full legal scope, please
refer to the issued patents linked above

 

 

Intelligent Living Application Group Inc. Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

HONG KONG, July 24, 2025 /PRNewswire/ — Intelligent Living Application Group Inc. (NASDAQ: ILAG) (“Intelligent Living” or the “Company”), a premium lockset manufacturer in Hong Kong, announced today that, on July 23, 2025, the Company received a written notification from the NASDAQ Stock Market Listing Qualifications Staff (the “Staff”) indicating that the Company has been granted an additional 180 calendar day period or until January 19, 2026, to regain compliance with the $1.00 minimum closing bid price requirement for continued listing on the NASDAQ Capital Market pursuant to NASDAQ Listing Rule (the “Minimum Bid Price Requirement”).

NASDAQ’s determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the NASDAQ Capital Market, with the exception of the bid price requirement, and the Company’s written notice to NASDAQ of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If at any time during this additional time period the closing bid price of the Company’s security is at least $1.00 per share for a minimum of 10 consecutive business days, NASDAQ will provide written confirmation of compliance and this matter will be closed. If compliance cannot be demonstrated by January 19, 2026, Staff will provide written notification that the Company’s securities will be delisted. At that time, the Company may appeal the Staff’s determination to a Hearings Panel (the “Panel”) of NASDAQ.

This notification from Nasdaq has no immediate effect on the listing or trading of the Company’s ordinary shares, which will continue to trade on the Nasdaq Capital Market under the symbol “ILAG”. The Company will monitor the closing bid price of its ordinary shares and will consider various options to regain compliance before January 19, 2026.

About Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc. is a premium lockset manufacturer and distributor headquartered in Hong Kong. Intelligent Living manufactures and sells high quality mechanical locksets to customers mainly in the United States and Canada and has continued to diversify and refine its product offerings in the past 40 years to meet its customers’ needs. Intelligent Living obtained the ISO9001 quality assurance certificate and various accredited quality and safety certificates including American National Standards Institute (ANSI) Grade 2 and Grade 3 standards that are developed by the Builders Hardware Manufacturing Association (BHMA) for ANSI. Intelligent Living keeps investing in self-designed automated product lines, new craftsmanship, and developing new products, including smart locks. For more information, visit the Company’s website at http://www.i-l-a-g.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC, which are available for review at www.sec.gov.

For more information, please contact:

Intelligent Living Application Group, Inc.
Phone: +852 2481 7938
Email info@i-l-a-g.com